2014 presents many new and expanded regulations that directly and indirectly impact the Private Equity industry in areas such as the market economy, litigation, regulation, and technology. Presented by CapLinked, join Foley and Thompson Reuters Risk for a Web conference on February 12 to discuss how your firm can be better prepared to manage the new types of risks facing PE Funds in 2014.
The Web conference will cover how to:
- Navigate the current market economy and how it impacts pricing and market trends.
- Avoid common litigation claims and conflicts of interest.
- Interpret what the Volcker Rule means for funds and how to comply accordingly.
- Utilize big data and handle a complex business ecosystem.
Speakers
- Gabor Garai is a partner at Foley & Lardner LLP. He is chair of the firm’s Private Equity & Venture Capital Practice and co-chair of the Life Sciences Team.
- Dave Curran is Global Director, Risk & Compliance with Thomson Reuters Risk and works with major clients to help address and mitigate systemic regulatory, compliance, risk and related challenges.
There is no cost to participate in this program, but pre-registration is required. To participate, please RSVP with CapLinked.
People
Related Insights
April 10, 2026
Energy Current
Mexico Plans to Reactivate Fracking by 2027
President Claudia Sheinbaum announced on April 8 a significant shift in Mexico’s energy policy by unveiling a project to exploit natural…
April 10, 2026
Energy Current
Proposed Legislation Pending in Oklahoma State Legislature Would Impact Responsibility for Payment of Costs Associated with Data Centers and Other Large Load Facilities
Several proposed bills targeting data centers have been proposed in the 2026 session of the Oklahoma State Legislature. Most of these…
April 9, 2026
Health Care Law Today
Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive
On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp products to eligible Medicare beneficiaries.